2m 2m 2m 2m 2m 2m 2m
GAIN THERAPEUTIC (GANX)
NASDAQ
$1.78+$0.01 (+0.85%)
Price as of Jul 14, 2026 7:13 AM EDT- $75.1MMarket Cap
- -5.38%1-Year Change
- BiotechnologyIndustry
GAIN THERAPEUTIC (GANX)
$1.78+$0.01 (+0.85%)
GANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.76 | ||
Change | -$0.04 (-2.22%) | ||
Open | $1.79 | ||
High | $1.85 | ||
Low | $1.74 | ||
Previous Close | $1.80 | ||
Volume | 997,398 | ||
30-Day Average Volume | 1,420,812 | ||
1-Week Change | -2.76% | ||
1-Month Change | 4.76% | ||
1-Year Change | -5.38% | ||
3-Year Change | -60.89% | ||
5-Year Change | -82.35% | ||
Fundamentals | |||
Shares Outstanding | 42.7M | ||
Total Assets | $18.7M | ||
Market Cap | $75.1M | ||
Enterprise Value | $58.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$5.6M | ||
Free Cash Flow | -$4.7M | ||
EBIT | -$5.4M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $14.3M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -14 | ||
PEG | 2 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue